Hubei Xiangyuan New Material Technology Inc. (300980.SZ) stock: key figures, P/E, revenue and dividend
Materials · Specialty Chemicals · China · ISIN CNE100004KQ2
Hubei Xiangyuan New Material Technology Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 475.86 m CNY | 603.49 m CNY |
| Gross profit | 137.58 m CNY | 170.81 m CNY |
| Operating income | 33.44 m CNY | 52.74 m CNY |
| EBIT | 50.40 m CNY | 52.02 m CNY |
| Net income | 25.58 m CNY | 49.70 m CNY |
| Diluted EPS – continuing operations | 0.24 CNY | 0.36 CNY |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hubei Xiangyuan New Material Technology Inc.
Hubei Xiangyuan New Material Technology Inc. engages in the research and development, production, and sale of cross-linked polyolefin and silicone foams in China and internationally. The company offers chemical crosslinked polyethylene foam, Irradiation crosslinked polyethylene foam, as well as IXPP, DZF, DPF, and DCF foam; polyurethane foam, such as INF series, USF series, CPF series, and WP series; and silicone foam, including SSF-T series and SSF-H Series. It also provides thermal runaway protection materials, supercritical foaming material, and flexible sensing materials. The company's products are used in automotive interiors, electronics, construction, package, medical, sports and leisure, building decoration materials, new energy vehicles, household appliances, and other fields. Hubei Xiangyuan New Material Technology Inc. was founded in 2003 and is headquartered in Hanchuan, China.
More stocks
- Beijing Trust Far Tech (300231.SZ)
- Binggrae (005180.KS)
- innoscripta (1INN.MU)
- Ningbo Solartron Technology Co Ltd (688299.SS)
- YungShin Global Holding Corp (3705.TW)
- Comp SA (CMP.WA)
- Zhejiang Yatai Pharmaceutical Co Ltd (002370.SZ)
- Atria Oyj (ATRAV.HE)
- Heren Health Co Ltd (300550.SZ)
- CRESCENT BIOPHARMA, INC. (CBIO)
- Zhejiang Zhengte Co Ltd (001238.SZ)
- CHO Pharma Inc. (6586.TWO)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.